Intercept Pharmaceuticals, Inc. (Nasdaq: ICPT) announced the filing of a New Drug Submission to Health Canada, seeking Canadian marketing approval ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE